Background: Data from New York State indicate that about 1 of every 33
,000 red cell units transfused is ABO-incompatible with the recipient.
National application of these data suggests that as many as 360 ABO-i
ncompatible whole blood and red cell transfusions might occur annually
in the United States. Phlebotomy and blood bank laboratory errors cau
se some of these ABO-incompatible transfusions, but the greatest numbe
r result either partially or solely from the failure of transfusionist
s to Identify properly either a patient or the blood component a patie
nt receives. Study Design and Methods: A quality assessment/quality im
provement (QA/QI) process is described that allowed for the direct ove
rsight (monitoring) Of transfusionists' practices and for the assessme
nt of institutional policies for blood administration. Results: At the
beginning of the QA/QI process, monitoring of blood administration pr
actices revealed that a variance from institutional blood administrati
on policy occurred during 50 percent of blood and component transfusio
ns. As a result of the QA/QI process, the percentage of transfusions w
ith an associated variance from institutional policy dropped to nearly
zero. Conclusion: The QA/QI process described in this report, or one
similar to it, could improve transfusion safety and serve as a model f
or increased involvement by transfusion service medical directors in t
he oversight of transfusionists' practices.